Skip to content
EXELIXIS, INC. (EXEL) Stock Price, Key Stats & Insider Trading
Home / Companies / EXEL EXE
EXELIXIS, INC. (EXEL) XNAS BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Net insider selling (90d)
Latest EXEL Insider Trades
About EXELIXIS, INC. (EXEL) Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Headquarters ALAMEDA, CA
Employees 1,077
Listed 2000
Exchange XNAS https://www.exelixis.com SEC filings for EXEL on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 3 23,549 $1.22M
EXEL Insider Transactions (Form 4) 81 77 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 2 of 3.
Date Insider Transaction Security Shares Price Value Feb 19, 2026 DA Dana Aftab - Officer Open-market sale Common Stock
Recent EXEL Form 8-K Filings 3
Recent EXEL Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 10, 2026 MARY BECKERLE Director 9,812 $526K View on EDGAR Jun 1, 2026 - -
EXEL Insider Trading - FAQ
What is the latest insider trade for EXEL? EXELIXIS, INC. (EXEL) had 3 insider filings in the last 90 days, with the most recent on 2026-08-12. The full record for EXEL runs to 77 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying EXEL stock? No insider purchases of EXEL were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling EXEL stock? 3 insider sales of EXEL were filed in the last 90 days, totaling $1.22M.
Where can I see EXEL SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks EXEL Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow EXEL insider buys? Create a free InsiderAlpha account and press Watch on this page to add EXEL to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track EXEL insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free DA Dana Aftab - Officer Open-market sale $2.19M
May 26, 2026
Market cap $13.49B
P/E ratio 30.70
Dividend yield -
Average volume 2.59M
52 week high $57.57
52 week low $33.76
Today's high $55.25
Today's low $54.12
Open $55.14
Volume 1.49M
Previous close $55.26
Shares outstanding 247.78M Market cap
$13.49B
1,077 employees
EXEL Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 3 sales totaling $1.22M.
Most-Active EXEL Insiders - Last 90 Days 10 Feb 17, 2026 JS Julie Smith - Director Option exercise Common Stock 42,422 $18.19 $772K
Feb 17, 2026 JS Julie Smith - Director Open-market sale Common Stock 42,422 $43.33 $1.84M
Feb 18, 2026 JS Julie Smith - Director Option exercise Common Stock 44,087 $19.39 $855K
Feb 18, 2026 JS Julie Smith - Director Open-market sale Common Stock 44,087 $44.50 $1.96M
Feb 18, 2026 JS Julie Smith - Director Option exercise Common Stock 20,030 $21.69 $434K
Feb 18, 2026 JS Julie Smith - Director Open-market sale Common Stock 20,030 $44.30 $887K
Feb 17, 2026 JS Julie Smith - Director Option exercise Option (right to buy) 42,422 $0.00 -
Feb 18, 2026 JS Julie Smith - Director Option exercise Option (right to buy) 44,087 $0.00 -
Feb 18, 2026 JS Julie Smith - Director Option exercise Option (right to buy) 20,030 $0.00 -
Feb 15, 2026 PH Patrick J. Haley - Officer Tax withholding / forfeiture Common Stock 31,483 $43.92 $1.38M
Feb 17, 2026 PH Patrick J. Haley - Officer Open-market sale Common Stock 3,036 $43.84 $133K
Feb 17, 2026 PH Patrick J. Haley - Officer Open-market sale Common Stock 64,778 $43.50 $2.82M
Feb 13, 2026 MM Michael Morrissey - Officer Option exercise Common Stock 494,700 $21.31 $10.54M
Feb 13, 2026 MM Michael Morrissey - Officer Tax withholding / forfeiture Common Stock 369,606 $43.92 $16.23M
Feb 15, 2026 MM Michael Morrissey - Officer Tax withholding / forfeiture Common Stock 120,390 $43.92 $5.29M
Feb 13, 2026 MM Michael Morrissey - Officer Option exercise Option (right to buy) 494,700 $0.00 -
Feb 13, 2026 SE Sue Gail Eckhardt - Director Open-market sale Common Stock 3,856 $43.79 $169K
Feb 15, 2026 DA Dana Aftab - Officer Tax withholding / forfeiture Common Stock 26,485 $43.92 $1.16M
Feb 15, 2026 DA Dana Aftab - Officer Tax withholding / forfeiture Common Stock 12,720 $43.92 $559K
Feb 13, 2026 BO Bob Oliver - Director Option exercise Common Stock 9,088 $19.28 $175K
Feb 13, 2026 BO Bob Oliver - Director Open-market sale Common Stock 9,088 $43.61 $396K
Feb 13, 2026 BO Bob Oliver - Director Open-market sale Common Stock 21,162 $43.90 $929K
Feb 13, 2026 BO Bob Oliver - Director Option exercise Option (right to buy) 9,088 $0.00 -
Feb 15, 2026 BH Brenda Hefti - Officer Tax withholding / forfeiture Common Stock 5,430 $43.92 $238K
Feb 18, 2026 BH Brenda Hefti - Officer Open-market sale Common Stock 18,669 $44.01 $822K
Jan 15, 2026 MM Michael Morrissey - Officer Tax withholding / forfeiture Common Stock 139,524 $45.23 $6.31M
Jan 15, 2026 DA Dana Aftab - Officer Grant or award Common Stock 119,578 $0.00 -
Jan 15, 2026 DA Dana Aftab - Officer Tax withholding / forfeiture Common Stock 27,254 $45.23 $1.23M
Jan 15, 2026 PH Patrick J. Haley - Officer Tax withholding / forfeiture Common Stock 32,332 $45.23 $1.46M
Nov 20, 2025 PH Patrick J. Haley - Officer Open-market sale Common Stock 10,000 $42.11 $421K
Nov 20, 2025 PH Patrick J. Haley - Officer Open-market sale Common Stock 23,539 $41.93 $987K
Nov 20, 2025 PH Patrick J. Haley - Officer Open-market sale Common Stock 10,648 $41.77 $445K
Nov 21, 2025 PH Patrick J. Haley - Officer Open-market sale Common Stock 28,043 $42.58 $1.19M
Nov 21, 2025 DA Dana Aftab - Officer Gift Common Stock 24,000 $0.00 -
Nov 17, 2025 BO Bob Oliver - Director Gift Common Stock 1,044 $0.00 -
Nov 11, 2025 MB Mary C. Beckerle - Director Option exercise Option (right to buy) 5,784 $0.00 -
Nov 11, 2025 MB Mary C. Beckerle - Director Option exercise Common Stock 5,784 $23.24 $134K
Nov 11, 2025 MB Mary C. Beckerle - Director Open-market sale Common Stock 5,784 $42.03 $243K
Nov 11, 2025 MB Mary C. Beckerle - Director Open-market sale Common Stock 18,838 $41.90 $789K
Nov 11, 2025 DA Dana Aftab - Officer Open-market sale Common Stock 48,383 $42.50 $2.06M
Oct 8, 2025 DA Dana Aftab - Officer Grant or award Common Stock 50,673 $0.00 -
May 29, 2025 GP George Poste - Director Grant or award Common Stock 9,812 $0.00 -
May 16, 2025 GP George Poste - Director Option exercise Common Stock 20,634 $19.77 $408K
May 16, 2025 GP George Poste - Director Open-market sale Common Stock 20,634 $45.99 $949K
May 16, 2025 GP George Poste - Director Option exercise Option (right to buy) 20,634 $0.00 -
May 14, 2025 MM Michael Morrissey - Officer Option exercise Common Stock 308,365 $18.80 $5.80M
May 14, 2025 MM Michael Morrissey - Officer Tax withholding / forfeiture Common Stock 220,494 $44.65 $9.85M
May 15, 2025 MM Michael Morrissey - Officer Tax withholding / forfeiture Common Stock 104,769 $44.65 $4.68M
May 14, 2025 MM Michael Morrissey - Officer Option exercise Option (right to buy) 308,365 $0.00 -
$FDMT
4D Molecular Therapeutics, Inc.
Dana Aftab - Officer
